Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

127.70 

-8.47 -6.2%

as of Oct 18 '19

52 Week Range:

121.00 148.99


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Equity (BVPS) 22.53
23.33
24.75
27.52
25.86
26.75
27.58
24.27
growth rate 3.6% 6.1% 11.2% -6.0% 1.7% 1.5% -12.0%
Earnings BIT 12,360.00
13,780.00
15,470.00
21,137.00
18,370.00
21,165.00
19,622.00
21,407.00
growth rate 11.5% 12.3% 36.6% -6.8% 7.3% -7.3% 9.1%
Avg.PE 18.83
18.18
19.05
17.98
19.44
19.44
20.88
283.30
23.94
growth rate -3.5% 4.8% -5.6% 8.1% 0.0% 3.6% 1,256.8% -91.6%
ROA 8.93
9.24
10.89
12.38
11.65
12.05
0.87
9.86
growth rate 3.5% 17.9% 13.7% -5.9% 1.7% -73.1% 1,033.3%
ROE 17.02
17.81
19.92
22.70
21.87
23.37
1.99
25.51
growth rate 4.6% 11.9% 14.0% -3.7% 3.4% -70.8% 1,181.9%
ROIC 13.31
14.22
16.39
18.47
17.55
17.86
1.69
16.90
growth rate 6.8% 15.3% 12.7% -5.0% 0.9% -69.2% 900.0%
Cur. Ratio 2.38
1.90
2.20
2.36
2.17
2.47
1.41
1.47
growth rate -20.2% 15.8% 7.3% -8.1% 6.7% -24.5% 4.3%
Quick Ratio 1.88
1.34
1.59
1.75
1.77
2.04
1.04
1.08
growth rate -28.7% 18.7% 10.1% 1.1% 7.4% -28.6% 3.9%
Leverage 1.99
1.87
1.79
1.88
1.88
2.01
2.61
2.56
growth rate -6.0% -4.3% 5.0% 0.0% 3.4% 14.0% -1.9%
Balance Sheet Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Acct.Receivable 10,581.00
14,448.00
15,320.00
10,985.00
10,734.00
11,699.00
13,490.00
14,098.00
growth rate 36.6% 6.0% -28.3% -1.2% 4.4% 15.3% 4.5%
Acct.Payable 19,586.00
20,823.00
7,633.00
6,668.00
6,918.00
7,310.00
7,537.00
growth rate 6.3% -63.3% -6.5% 1.9% 5.7% 3.1%
Cur.Assets 54,316.00
46,116.00
56,407.00
55,744.00
60,210.00
65,032.00
43,088.00
46,033.00
growth rate -15.1% 22.3% -1.2% 3.9% 3.9% -33.7% 6.8%
Total Assets 113,644.00
121,347.00
132,683.00
130,358.00
133,411.00
141,208.00
157,303.00
152,954.00
growth rate 6.8% 9.3% -1.8% 1.2% 2.9% 11.4% -2.8%
Cash 24,542.00
14,911.00
20,927.00
14,523.00
13,732.00
18,972.00
17,824.00
18,107.00
growth rate -39.2% 40.4% -30.6% -2.8% 17.5% -6.1% 1.6%
Inventory 6,285.00
7,495.00
7,878.00
8,184.00
8,053.00
8,144.00
8,765.00
8,599.00
growth rate 19.3% 5.1% 3.9% -0.8% 0.6% 7.6% -1.9%
Cur.Liabilities 22,811.00
24,262.00
25,675.00
25,031.00
27,747.00
26,287.00
30,537.00
31,230.00
growth rate 6.4% 5.8% -2.5% 5.3% -2.7% 16.2% 2.3%
Liabilities 56,564.00
56,521.00
58,630.00
60,606.00
62,261.00
70,790.00
97,143.00
93,202.00
growth rate -0.1% 3.7% 3.4% 1.4% 6.6% 37.2% -4.1%
LT Debt 12,969.00
11,489.00
13,328.00
15,130.00
13,096.00
22,824.00
30,684.00
27,687.00
growth rate -11.4% 16.0% 13.5% -7.0% 32.0% 34.4% -9.8%
Equity 57,080.00
64,826.00
74,053.00
69,752.00
71,150.00
70,418.00
60,160.00
59,752.00
growth rate 13.6% 14.2% -5.8% 1.0% -0.5% -14.6% -0.7%
Common Shares 2,775.00
2,812.00
2,877.00
2,864.00
3,120.00
3,120.00
3,120.00
2,745.00
2,728.00
growth rate 1.3% 2.3% -0.5% 8.9% 0.0% 0.0% -12.0% -0.6%
Cash Flow Statement Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Capital Expenditures 1,551.00
2,934.00
3,595.00
3,714.00
3,463.00
3,226.00
3,279.00
3,670.00
growth rate 89.2% 22.5% 3.3% -3.4% -3.5% 1.6% 11.9%
Cash Dividends 6,156.00
6,614.00
7,286.00
7,768.00
8,173.00
8,621.00
8,943.00
9,494.00
growth rate 7.4% 10.2% 6.6% 2.6% 2.7% 3.7% 6.2%
Cash From OA 14,298.00
15,396.00
17,414.00
18,710.00
19,569.00
18,767.00
21,056.00
22,201.00
growth rate 7.7% 13.1% 7.4% 2.3% -2.1% 12.2% 5.4%
FCF per Share 4.30
4.43
4.65
5.08
5.30
4.79
6.71
6.76
growth rate 3.0% 5.0% 9.3% 4.3% -4.9% 18.4% 0.8%
Sale Purchase of Stock -10,199.00
-889.00
1,543.00
1,005.00
1,189.00
1,062.00
growth rate 0.0% 100.0% -19.3% 8.8% -10.7%
FCF 11,405.00
12,462.00
13,819.00
14,757.00
15,816.00
16,106.00
15,541.00
15,541.00
17,777.00
18,531.00
growth rate 9.3% 10.9% 6.8% 7.2% 1.8% -3.5% 0.0% 14.4% 4.2%
Income Statement Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Sales 65,030.00
67,224.00
71,312.00
74,331.00
70,074.00
71,890.00
76,450.00
81,581.00
growth rate 3.4% 6.1% 4.2% -2.9% 1.3% 6.3% 6.7%
Op.Income 16,153.00
10,853.00
13,831.00
21,137.00
18,370.00
21,165.00
19,622.00
21,407.00
growth rate -32.8% 27.4% 52.8% -6.8% 7.3% -7.3% 9.1%
IBT 12,361.00
13,775.00
15,471.00
20,563.00
19,196.00
19,803.00
17,673.00
17,999.00
growth rate 11.4% 12.3% 32.9% -3.4% 1.6% -10.8% 1.8%
Net Income 9,672.00
10,853.00
13,831.00
16,323.00
15,409.00
16,540.00
1,300.00
15,297.00
growth rate 12.2% 27.4% 18.0% -2.8% 3.6% -92.1% 1,076.7%
EPS 3.49
3.86
4.81
5.70
5.48
5.93
0.47
5.61
growth rate 10.6% 24.6% 18.5% -3.9% 4.0% -71.9% 1,093.6%
Gross Profit 44,670.00
45,566.00
48,970.00
51,585.00
48,619.00
50,101.00
51,511.00
54,595.00
growth rate 2.0% 7.5% 5.3% -2.9% 1.5% 2.8% 6.0%
R&D 7,548.00
7,665.00
8,183.00
8,494.00
9,046.00
9,143.00
10,594.00
10,775.00
growth rate 1.6% 6.8% 3.8% 3.2% 0.5% 15.9% 1.7%

Quarterly Statements

Item Name Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Earnings BIT 5,752.00
5,760.00
4,355.00
5,448.00
5,530.00
growth rate 0.1% -24.4% 25.1% 1.5%
Balance Sheet Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 14,166.00
14,048.00
14,098.00
14,115.00
14,653.00
growth rate -0.8% 0.4% 0.1% 3.8%
Acct.Payable 6,443.00
7,000.00
7,537.00
6,923.00
6,912.00
growth rate 8.7% 7.7% -8.2% -0.2%
Cur.Assets 42,768.00
47,194.00
46,033.00
41,987.00
41,799.00
growth rate 10.4% -2.5% -8.8% -0.5%
Total Assets 156,625.00
155,703.00
152,954.00
150,027.00
155,117.00
growth rate -0.6% -1.8% -1.9% 3.4%
Cash 14,639.00
16,056.00
18,107.00
14,734.00
14,376.00
growth rate 9.7% 12.8% -18.6% -2.4%
Inventory 9,014.00
8,678.00
8,599.00
9,086.00
9,263.00
growth rate -3.7% -0.9% 5.7% 2.0%
Cur.Liabilities 27,081.00
27,437.00
31,230.00
29,111.00
31,353.00
growth rate 1.3% 13.8% -6.8% 7.7%
Liabilities 93,370.00
91,077.00
93,202.00
91,072.00
94,332.00
growth rate -2.5% 2.3% -2.3% 3.6%
LT Debt 29,851.00
29,486.00
27,687.00
27,662.00
27,700.00
growth rate -1.2% -6.1% -0.1% 0.1%
Equity 63,255.00
64,626.00
59,752.00
58,955.00
60,785.00
growth rate 2.2% -7.5% -1.3% 3.1%
Common Shares 3,120.00
3,120.00
3,120.00
3,120.00
3,120.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 658.00
819.00
1,318.00
656.00
837.00
growth rate 24.5% 60.9% -50.2% 27.6%
Cash Dividends 2,253.00
2,415.00
2,411.00
2,396.00
2,522.00
growth rate 7.2% -0.2% -0.6% 5.3%
Cash From OA 3,606.00
6,272.00
6,244.00
3,543.00
5,948.00
growth rate 73.9% -0.5% -43.3% 67.9%
Sale Purchase of Stock 66.00
96.00
growth rate 45.5%
FCF 2,948.00
5,453.00
4,926.00
2,887.00
5,111.00
growth rate 85.0% -9.7% -41.4% 77.0%
Income Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Sales 20,009.00
20,348.00
20,394.00
20,021.00
20,562.00
growth rate 1.7% 0.2% -1.8% 2.7%
Op.Income 5,752.00
5,760.00
4,355.00
5,448.00
5,530.00
growth rate 0.1% -24.4% 25.1% 1.5%
IBT 5,481.00
4,423.00
3,122.00
4,422.00
7,041.00
growth rate -19.3% -29.4% 41.6% 59.2%
Net Income 4,367.00
3,934.00
3,042.00
3,749.00
5,607.00
growth rate -9.9% -22.7% 23.2% 49.6%
EPS
growth rate
Gross Profit 13,401.00
13,782.00
13,538.00
13,429.00
13,660.00
growth rate 2.8% -1.8% -0.8% 1.7%
R&D 2,404.00
2,508.00
3,224.00
2,858.00
2,666.00
growth rate 4.3% 28.6% -11.4% -6.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (32.40)

YOY Growth Grade:

D (40.19)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 21.21 21.21 13.99
EPS / Growth 6.8% 6.02 7.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 5.2% 5.2%
Future PE 2.00 15.20 15.20
Future EPS 6.65 10.00 10.00
Value Price
MOS %
3.29
-97.4%
37.55
-70.6%
37.55
-70.6%
MOS Price 1.64 18.78 18.78
IRT 19.16 14.14 14.14

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.